Skip to content
Visnia
CtrlK
EconomyAI buildoutMarket MapFundsWatchlist
Log in
Market cap
Revenue
Net income
Cash on hand
Gross margin
Net margin
EPS
P/E ratio
Search
Market mapFundsWatchlist
Visnia

SSELLAS Life Sciences Group, Inc.

EconomyAI buildoutMarket MapFundsWatchlist
Log in
S

SELLAS Life Sciences Group, Inc.

  • Overview
  • Financial statements
  • Metrics
  • Quarterly earnings
  • Similar companies
  • News
  • Insider Transactions

News

News

  • SELLAS Life Sciences Presents Preclinical Data Demonstrating SLS009 Activity in Pancreatic Cancer Models at the 2026 AACR Conference on Pancreatic Cancer
    Sep 25, 2026Sellas Life Sciences Press Releases
  • SELLAS Life Sciences to Present Preclinical Data on SLS009 in Pancreatic Ductal Adenocarcinoma at the 2026 AACR Conference on Pancreatic Cancer
    Sep 2, 2026Sellas Life Sciences Press Releases
  • SELLAS Life Sciences Reports Second Quarter 2026 Financial Results and Provides Corporate Update
    Aug 11, 2026Sellas Life Sciences Press Releases
  • SELLAS Life Sciences to Participate in Upcoming Investor Conferences
    May 14, 2026Sellas Life Sciences Press Releases
  • SELLAS Life Sciences Reports First Quarter 2026 Financial Results and Provides Corporate Update
    May 12, 2026Sellas Life Sciences Press Releases
  • SELLAS Life Sciences Reports Full Year 2025 Financial Results and Provides Corporate Update
    Mar 19, 2026Sellas Life Sciences Press Releases
  • SELLAS Life Sciences to Present Preclinical Data Highlighting Potent Activity of SLS009 in AML at the 2026 AACR Conference
    Mar 17, 2026Sellas Life Sciences Press Releases
  • SELLAS Life Sciences Announces Enrollment of First Patient in Newly Diagnosed First-Line AML Trial of SLS009
    Mar 12, 2026Sellas Life Sciences Press Releases
  • SELLAS Life Sciences Enters Agreement with IMPACT-AML to Expand SLS009 Clinical Program into Europe
    Jan 14, 2026Sellas Life Sciences Press Releases
  • SELLAS Life Sciences Provides Update on Pivotal Phase 3 REGAL Trial of Galinpepimut-S (GPS) in Acute Myeloid Leukemia (AML)
    Dec 29, 2025Sellas Life Sciences Press Releases
  • Overview
  • Financial statements
  • Metrics
  • Quarterly earnings
  • Burn Rate
  • Similar companies
  • News
  • Insider Transactions
$12.02Close ยท Sep 22, 2026